{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:32:37Z","timestamp":1789183957103,"version":"build-2803163510"},"reference-count":239,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research, Development, and Innovation Office","award":["NKFIH K138125"],"award-info":[{"award-number":["NKFIH K138125"]}]},{"name":"National Research, Development, and Innovation Office","award":["2022\/5S729"],"award-info":[{"award-number":["2022\/5S729"]}]},{"name":"National Research, Development, and Innovation Office","award":["TKP-2021-EGA-32"],"award-info":[{"award-number":["TKP-2021-EGA-32"]}]},{"name":"SZTE SZAOK-KKA","award":["NKFIH K138125"],"award-info":[{"award-number":["NKFIH K138125"]}]},{"name":"SZTE SZAOK-KKA","award":["2022\/5S729"],"award-info":[{"award-number":["2022\/5S729"]}]},{"name":"SZTE SZAOK-KKA","award":["TKP-2021-EGA-32"],"award-info":[{"award-number":["TKP-2021-EGA-32"]}]},{"name":"HUN-REN Hungarian Research Network","award":["NKFIH K138125"],"award-info":[{"award-number":["NKFIH K138125"]}]},{"name":"HUN-REN Hungarian Research Network","award":["2022\/5S729"],"award-info":[{"award-number":["2022\/5S729"]}]},{"name":"HUN-REN Hungarian Research Network","award":["TKP-2021-EGA-32"],"award-info":[{"award-number":["TKP-2021-EGA-32"]}]},{"name":"Ministry of Human Capacities, Hungary grant","award":["NKFIH K138125"],"award-info":[{"award-number":["NKFIH K138125"]}]},{"name":"Ministry of Human Capacities, Hungary grant","award":["2022\/5S729"],"award-info":[{"award-number":["2022\/5S729"]}]},{"name":"Ministry of Human Capacities, Hungary grant","award":["TKP-2021-EGA-32"],"award-info":[{"award-number":["TKP-2021-EGA-32"]}]},{"name":"\u00daNKP-22-4-SZTE-166 New National Excellence Program of the Ministry for Culture and Innovation","award":["NKFIH K138125"],"award-info":[{"award-number":["NKFIH K138125"]}]},{"name":"\u00daNKP-22-4-SZTE-166 New National Excellence Program of the Ministry for Culture and Innovation","award":["2022\/5S729"],"award-info":[{"award-number":["2022\/5S729"]}]},{"name":"\u00daNKP-22-4-SZTE-166 New National Excellence Program of the Ministry for Culture and Innovation","award":["TKP-2021-EGA-32"],"award-info":[{"award-number":["TKP-2021-EGA-32"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The central nervous system (CNS) is the final frontier in drug delivery because of the blood\u2013brain barrier (BBB), which poses significant barriers to the access of most drugs to their targets. Kynurenic acid (KYNA), a tryptophan (Trp) metabolite, plays an important role in behavioral functions, and abnormal KYNA levels have been observed in neuropsychiatric conditions. The current challenge lies in delivering KYNA to the CNS owing to its polar side chain. Recently, C-3 side chain-modified KYNA analogs have been shown to cross the BBB; however, it is unclear whether they retain the biological functions of the parent molecule. This study examined the impact of KYNA analogs, specifically, SZR-72, SZR-104, and the newly developed SZRG-21, on behavior. The analogs were administered intracerebroventricularly (i.c.v.), and their effects on the motor domain were compared with those of KYNA. Specifically, open-field (OF) and rotarod (RR) tests were employed to assess motor activity and skills. SZR-104 increased horizontal exploratory activity in the OF test at a dose of 0.04 \u03bcmol\/4 \u03bcL, while SZR-72 decreased vertical activity at doses of 0.04 and 0.1 \u03bcmol\/4 \u03bcL. In the RR test, however, neither KYNA nor its analogs showed any significant differences in motor skills at either dose. Side chain modification affects affective motor performance and exploratory behavior, as the results show for the first time. In this study, we showed that KYNA analogs alter emotional components such as motor-associated curiosity and emotions. Consequently, drug design necessitates the development of precise strategies to traverse the BBB while paying close attention to modifications in their effects on behavior.<\/jats:p>","DOI":"10.3390\/ijms25063394","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T05:14:07Z","timestamp":1710738847000},"page":"3394","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Impact of C-3 Side Chain Modifications on Kynurenic Acid: A Behavioral Analysis of Its Analogs in the Motor Domain"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7596-9965","authenticated-orcid":false,"given":"Di\u00e1na","family":"Martos","sequence":"first","affiliation":[{"name":"HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, University of Szeged, Danube Neuroscience Research Laboratory, Tisza Lajos krt. 113, H-6725 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-0034","authenticated-orcid":false,"given":"B\u00e1lint","family":"L\u0151rinczi","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Chemistry and HUN-REN\u2013SZTE Stereochemistry Research Group, University of Szeged, E\u00f6tv\u00f6s u. 6, H-6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8571-5229","authenticated-orcid":false,"given":"Istv\u00e1n","family":"Szatm\u00e1ri","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Chemistry and HUN-REN\u2013SZTE Stereochemistry Research Group, University of Szeged, E\u00f6tv\u00f6s u. 6, H-6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[{"name":"HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, University of Szeged, Danube Neuroscience Research Laboratory, Tisza Lajos krt. 113, H-6725 Szeged, Hungary"},{"name":"Department of Neurology, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged, Semmelweis u. 6, H-6725 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4383-4024","authenticated-orcid":false,"given":"Masaru","family":"Tanaka","sequence":"additional","affiliation":[{"name":"HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, University of Szeged, Danube Neuroscience Research Laboratory, Tisza Lajos krt. 113, H-6725 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1037\/0022-006X.60.3.329","article-title":"Neural mechanisms of emotion","volume":"60","author":"Derryberry","year":"1992","journal-title":"J. Consult. Clin. Psychol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tics.2017.03.002","article-title":"A Network Model of the Emotional Brain","volume":"21","author":"Pessoa","year":"2017","journal-title":"Trends Cogn. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"J\u00e1szber\u00e9nyi, M., Thurz\u00f3, B., Bagosi, Z., V\u00e9csei, L., and Tanaka, M. (2024). The Orexin\/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress. Biomedicines, 12.","DOI":"10.3390\/biomedicines12020448"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Szab\u00f3, \u00c1., K\u00f6rt\u00e9si, T., Szok, D., Tajti, J., and V\u00e9csei, L. (2023). From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment. Cells, 12.","DOI":"10.20944\/preprints202309.0459.v2"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tajti, J., Szok, D., Cs\u00e1ti, A., Szab\u00f3, \u00c1., Tanaka, M., and V\u00e9csei, L. (2023). Exploring novel therapeutic targets in the common pathogenic factors in migraine and neuropathic pain. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202301.0034.v1"},{"key":"ref_6","unstructured":"Zigmond, M.J., Wiley, C.A., and Chesselet, M.-F. (2022). Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders, Academic Press."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bors, L.A., and Erd\u0151, F. (2019). Overcoming the blood\u2013brain barrier. challenges and tricks for CNS drug delivery. Sci. Pharm., 87.","DOI":"10.3390\/scipharm87010006"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/17425240902758188","article-title":"Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases","volume":"6","author":"Barchet","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6564585","DOI":"10.1155\/2021\/6564585","article-title":"Blood-brain barrier overview: Structural and functional correlation","volume":"2021","author":"Alahmari","year":"2021","journal-title":"Neural Plast."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"661838","DOI":"10.3389\/fncel.2021.661838","article-title":"Blood-brain barrier dysfunction amplifies the development of neuroinflammation: Understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction","volume":"15","author":"Takata","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zinserling, V. (2022). Infectious Lesions of the Central Nervous System, Springer.","DOI":"10.1007\/978-3-030-96260-9"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00232-015-9778-9","article-title":"Permeability of the blood\u2013brain barrier: Molecular mechanism of transport of drugs and physiologically important compounds","volume":"248","author":"Fong","year":"2015","journal-title":"J. Membr. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12031-007-0055-y","article-title":"The role of size and charge for blood\u2013brain barrier permeation of drugs and fatty acids","volume":"33","author":"Seelig","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","article-title":"Delivery of therapeutic agents to the central nervous system: The problems and the possibilities","volume":"104","author":"Begley","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"ref_16","unstructured":"Segal, M., and Zlokovic, B.V. (2012). The Blood-Brain Barrier, Amino Acids and Peptides, Springer Science & Business Media."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-4835(77)80016-X","article-title":"The blood-brain barrier","volume":"25","author":"Oldendorf","year":"1977","journal-title":"Exp. Eye Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/10717544.2019.1616235","article-title":"A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain\/brain tumor barriers for glioblastoma treatment","volume":"26","author":"Wang","year":"2019","journal-title":"Drug Deliv."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2174\/092986707780597943","article-title":"Molecular anatomy of the brain endothelial barrier: An overview of the distributional features","volume":"14","author":"Ueno","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0196-9781(01)00537-X","article-title":"Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability","volume":"22","author":"Witt","year":"2001","journal-title":"Peptides"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13152","DOI":"10.1021\/acs.jmedchem.1c00910","article-title":"Strategies for structural modification of small molecules to improve blood\u2013brain barrier penetration: A recent perspective","volume":"64","author":"Xiong","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chung, S., Yi, Y., Ullah, I., Chung, K., Park, S., Lim, J., Kim, C., Pyun, S.-H., Kim, M., and Kim, D. (2024). Systemic Treatment with Fas-Blocking Peptide Attenuates Apoptosis in Brain Ischemia. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010661"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11868","DOI":"10.1002\/anie.201801361","article-title":"Emerging methods and design principles for cell-penetrant peptides","volume":"57","author":"Peraro","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1021\/jm901654x","article-title":"N-methyl phenylalanine-rich peptides as highly versatile blood\u2013brain barrier shuttles","volume":"53","author":"Malakoutikhah","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/acs.accounts.7b00204","article-title":"Jumping hurdles: Peptides able to overcome biological barriers","volume":"50","author":"Teixido","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/17425240903081705","article-title":"Targeting anti-HIV drugs to the CNS","volume":"6","author":"Rao","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2015.12.041","article-title":"Concepts, technologies, and practices for drug delivery past the blood\u2013brain barrier to the central nervous system","volume":"240","author":"Crawford","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.2174\/1381612826666200224112534","article-title":"Drug development for central nervous system diseases using in vitro blood-brain barrier models and drug repositioning","volume":"26","author":"Morofuji","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/14656566.2021.1910235","article-title":"Are 5-HT1 receptor agonists effective anti-migraine drugs?","volume":"22","author":"Tanaka","year":"2021","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_30","unstructured":"Arnao, M., and Hern\u00e1ndez-Ruiz, J. (2015). Amino Acids in Higher Plants, CAB International."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Gao, J., Xu, K., Liu, H., Liu, G., Bai, M., Peng, C., Li, T., and Yin, Y. (2018). Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00013"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Barik, S. (2020). The uniqueness of tryptophan in biology: Properties, metabolism, interactions and localization in proteins. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228776"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-079X.2008.00580.x","article-title":"Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species","volume":"45","author":"Peyrot","year":"2008","journal-title":"J. Pineal Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"eaaf9794","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: Tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2741\/4363","article-title":"Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation","volume":"20","author":"Wang","year":"2015","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"110770","DOI":"10.1016\/j.exger.2019.110770","article-title":"Kynurenine pathway and human systems","volume":"129","author":"Badawy","year":"2020","journal-title":"Exp. Gerontol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000068","article-title":"Tryptophan metabolism in the central nervous system: Medical implications","volume":"8","author":"Ruddick","year":"2006","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2174\/156720501205150526114000","article-title":"Alzheimer\u2019s disease, astrocytes and kynurenines","volume":"12","author":"Dezsi","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Szab\u00f3, \u00c1., Spekker, E., Poly\u00e1k, H., T\u00f3th, F., and V\u00e9csei, L. (2022). Mitochondrial impairment: A common motif in neuropsychiatric presentation? The link to the tryptophan\u2013kynurenine metabolic system. Cells, 11.","DOI":"10.20944\/preprints202207.0130.v1"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.9758\/cpn.2020.18.4.507","article-title":"Kynurenine pathway of tryptophan metabolism in neuropsychiatric disorders: Pathophysiologic and therapeutic considerations","volume":"18","author":"Muneer","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41380-019-0401-9","article-title":"Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia","volume":"25","author":"Kindler","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"134576","DOI":"10.1016\/j.neulet.2019.134576","article-title":"Impaired metabolism of kynurenine and its metabolites in CSF of parkinson\u2019s disease","volume":"714","author":"Iwaoka","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s007020050149","article-title":"Kynurenine metabolism in Alzheimer\u2019s disease","volume":"106","author":"Baran","year":"1999","journal-title":"J. Neural Transm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.08.005","article-title":"The kynurenine pathway in neurodegenerative diseases: Mechanistic and therapeutic considerations","volume":"323","author":"Tan","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"ref_45","unstructured":"Urba\u0144ska, E.M., Chmiel-Perzy\u0144ska, I., Perzy\u0144ski, A., Derkacz, M., and Owe-Larsson, B. (2021). Handbook of Neurotoxicity, Springer."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14728222.2018.1524877","article-title":"Rollercoaster ride of kynurenines: Steering the wheel towards neuroprotection in Alzheimer\u2019s disease","volume":"22","author":"Sharma","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"775","DOI":"10.17219\/acem\/139572","article-title":"Monitoring the kynurenine system: Concentrations, ratios or what else?","volume":"30","author":"Tanaka","year":"2021","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Poly\u00e1k, H., Galla, Z., N\u00e1n\u00e1si, N., Cseh, E.K., Rajda, C., Veres, G., Spekker, E., Szab\u00f3, \u00c1., Kliv\u00e9nyi, P., and Tanaka, M. (2023). The tryptophan-kynurenine metabolic system is suppressed in cuprizone-induced model of demyelination simulating progressive multiple sclerosis. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030945"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Mor, A., Tankiewicz-Kwedlo, A., Krupa, A., and Pawlak, D. (2021). Role of kynurenine pathway in oxidative stress during neurodegenerative disorders. Cells, 10.","DOI":"10.3390\/cells10071603"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/FBP.0000000000000477","article-title":"The \u2018Yin\u2019and the \u2018Yang\u2019of the kynurenine pathway: Excitotoxicity and neuroprotection imbalance in stress-induced disorders","volume":"30","author":"Barone","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref_52","unstructured":"Maddison, D.C., and Giorgini, F. (2015). Seminars in Cell & Developmental Biology, Academic Press."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2174\/187152707783399229","article-title":"Kynurenine pathway and disease: An overview","volume":"6","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Tao, X., Yan, M., Wang, L., Zhou, Y., Wang, Z., Xia, T., Liu, X., Pan, R., and Chang, Q. (2020). Homeostasis imbalance of microglia and astrocytes leads to alteration in the metabolites of the kynurenine pathway in LPS-induced depressive-like mice. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041460"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuropharm.2016.01.011","article-title":"L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences","volume":"112","author":"Fujigaki","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3389\/fimmu.2019.02565","article-title":"Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target","volume":"10","author":"Sorgdrager","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cns.13768","article-title":"Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?","volume":"28","author":"Ostapiuk","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s40495-019-00208-2","article-title":"Neuropathology of kynurenine pathway of tryptophan metabolism","volume":"6","author":"Tutakhail","year":"2020","journal-title":"Curr. Pharmacol. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1515\/revneuro-2022-0047","article-title":"The role and mechanism of tryptophan\u2013kynurenine metabolic pathway in depression","volume":"34","author":"Gong","year":"2023","journal-title":"Rev. Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1021\/acschemneuro.7b00229","article-title":"Multifunctional Analogs of Kynurenic Acid for the Treatment of Alzheimer\u2019s Disease: Synthesis, Pharmacology, and Molecular Modeling Studies","volume":"8","author":"Deora","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Bratek-Gerej, E., Ziembowicz, A., Godlewski, J., and Salinska, E. (2021). The mechanism of the neuroprotective effect of kynurenic acid in the experimental model of neonatal hypoxia\u2013ischemia: The link to oxidative stress. Antioxidants, 10.","DOI":"10.3390\/antiox10111775"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Toldi, J., and V\u00e9csei, L. (2020). Exploring the etiological links behind neurodegenerative diseases: Inflammatory cytokines and bioactive kynurenines. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072431"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Tanaka, M., T\u00f3th, F., Poly\u00e1k, H., Szab\u00f3, \u00c1., M\u00e1ndi, Y., and V\u00e9csei, L. (2021). Immune influencers in action: Metabolites and enzymes of the tryptophan-kynurenine metabolic pathway. Biomedicines, 9.","DOI":"10.20944\/preprints202106.0344.v1"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"265","DOI":"10.31083\/j.fbl2709265","article-title":"Single Nucleotide Polymorphisms of Indoleamine 2, 3-Dioxygenase 1 Influenced the Age Onset of Parkinson\u2019s Disease","volume":"27","author":"Szolnoki","year":"2022","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Tanaka, M., and Vecsei, L. (2020). Monitoring the redox status in multiple sclerosis. Biomedicines, 8.","DOI":"10.3390\/biomedicines8100406"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1196\/annals.1403.003","article-title":"Genetic and hormonal regulation of tryptophan\u2013kynurenine metabolism: Implications for vascular cognitive impairment, major depressive disorder, and aging","volume":"1122","author":"Oxenkrug","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1217090","DOI":"10.3389\/fnmol.2023.1217090","article-title":"Activated Tryptophan-Kynurenine metabolic system in the human brain is associated with learned fear","volume":"16","author":"Battaglia","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cortex.2023.10.013","article-title":"Task-related modulation of motor response to emotional bodies: A TMS motor-evoked potential study","volume":"171","author":"Borgomaneri","year":"2024","journal-title":"Cortex"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Tortora, F., Hadipour, A.L., Battaglia, S., Falzone, A., Avenanti, A., and Vicario, C.M. (2023). The role of Serotonin in fear learning and memory: A systematic review of human studies. Brain Sci., 13.","DOI":"10.3390\/brainsci13081197"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/acps.13602","article-title":"Heart\u2019s tale of trauma: Fear-conditioned heart rate changes in post-traumatic stress disorder","volume":"148","author":"Battaglia","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2174\/1381612822666151230110738","article-title":"Cognition and emotions in recurrent depressive disorders-the role of inflammation and the kynurenine pathway","volume":"22","author":"Talarowska","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/j.1471-4159.2006.03677.x","article-title":"Is endogenous d-serine in the rostral anterior cingulate cortex necessary for pain-related negative affect?","volume":"96","author":"Ren","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Battaglia, S., Avenanti, A., V\u00e9csei, L., and Tanaka, M. (2024). Neural Correlates and Molecular Mechanisms of Memory and Learning. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052724"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Battaglia, S., Avenanti, A., V\u00e9csei, L., and Tanaka, M. (2024). Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical and Translational Neuropsychiatry. Biomedicines, 12.","DOI":"10.20944\/preprints202402.0879.v1"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41380-021-01326-4","article-title":"Does the human ventromedial prefrontal cortex support fear learning, fear extinction or both? A commentary on subregional contributions","volume":"27","author":"Battaglia","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1523\/JNEUROSCI.0304-20.2020","article-title":"Revaluing the role of vmPFC in the acquisition of Pavlovian threat conditioning in humans","volume":"40","author":"Battaglia","year":"2020","journal-title":"J. Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.cub.2020.06.091","article-title":"State-dependent TMS over prefrontal cortex disrupts fear-memory reconsolidation and prevents the return of fear","volume":"30","author":"Borgomaneri","year":"2020","journal-title":"Curr. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jns.2017.02.053","article-title":"Kynurenic acid and its analogue can alter the opioid receptor G-protein signaling after acute treatment via NMDA receptor in rat cortex and striatum","volume":"376","author":"Samavati","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"107807","DOI":"10.1016\/j.pharmthera.2021.107807","article-title":"Addiction and the kynurenine pathway: A new dancing couple?","volume":"223","author":"Vidal","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_83","unstructured":"Klausing, A.D. (2020). Effects of Acute Stress on Discriminative Fear Conditioning: A Key Role of Kynurenic Acid in the Medial Prefrontal Cortex. [Ph.D. Thesis, University of Maryland]."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2020.01.159","article-title":"Brain-derived neurotrophic factor association with amygdala response in major depressive disorder","volume":"267","author":"Lorenzetti","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"7215684","DOI":"10.1155\/2016\/7215684","article-title":"Acute psychological stress modulates the expression of enzymes involved in the kynurenine pathway throughout corticolimbic circuits in adult male rats","volume":"2016","author":"Vecchiarelli","year":"2016","journal-title":"Neural Plast."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Szab\u00f3, \u00c1., L\u0151rinczi, B., Szatm\u00e1ri, I., F\u00fcl\u00f6p, F., and V\u00e9csei, L. (2021, January 1\u201326). Antidepressant-like Effects of Kynurenic Acid Analogues. Presented at the 1st International Electronic Conference on Biomedicine, Online. Available online: https:\/\/sciforum.net\/paper\/view\/10301.","DOI":"10.3390\/ECB2021-10301"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"913303","DOI":"10.3389\/fpsyt.2022.913303","article-title":"Imbalances in kynurenines as potential biomarkers in the diagnosis and treatment of psychiatric disorders","volume":"13","author":"Myint","year":"2022","journal-title":"Front. Psychiatry"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Battaglia, S., Di Fazio, C., Vicario, C.M., and Avenanti, A. (2023). Neuropharmacological modulation of N-methyl-D-aspartate, noradrenaline and endocannabinoid receptors in fear extinction learning: Synaptic transmission and plasticity. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065926"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.biopsych.2021.05.021","article-title":"The kynurenine pathway in traumatic brain injury: Implications for psychiatric outcomes","volume":"91","author":"Meier","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Boh\u00e1r, Z., and V\u00e9csei, L. (2020). Are kynurenines accomplices or principal villains in dementia? Maintenance of kynurenine metabolism. Molecules, 25.","DOI":"10.3390\/molecules25030564"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000515066","article-title":"Galantamine-memantine combination and kynurenine pathway enzyme inhibitors in the treatment of neuropsychiatric disorders","volume":"7","author":"Bai","year":"2021","journal-title":"Complex Psychiatry"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2225800","DOI":"10.1080\/14756366.2023.2225800","article-title":"Research progress on the kynurenine pathway in the prevention and treatment of Parkinson\u2019s disease","volume":"38","author":"Chen","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"858","DOI":"10.14336\/AD.2022.0916","article-title":"Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies","volume":"14","author":"Huang","year":"2023","journal-title":"Aging Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"10409","DOI":"10.1007\/s11033-023-08859-7","article-title":"Kynurenine pathway and its role in neurologic, psychiatric, and inflammatory bowel diseases","volume":"50","author":"Sheibani","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.2174\/0929867322666150608094054","article-title":"Kynurenine aminotransferases and the prospects of inhibitors for the treatment of schizophrenia","volume":"22","author":"Sun","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1471-4159.1990.tb01207.x","article-title":"The glycine site of the N-methyl-D-aspartate receptor channel: Differences between the binding of HA-966 and of 7-chlorokynurenic acid","volume":"54","author":"Kloog","year":"1990","journal-title":"J. Neurochem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuropharm.2009.06.003","article-title":"Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels","volume":"57","author":"Mok","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2006.03.051","article-title":"Kynurenic acid has a dual action on AMPA receptor responses","volume":"402","author":"Prescott","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00702-008-0052-5","article-title":"The Janus-face kynurenic acid","volume":"115","author":"Robotka","year":"2008","journal-title":"J. Neural Transm."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.mcn.2011.05.001","article-title":"Mechanisms underlying NMDA receptor synaptic\/extrasynaptic distribution and function","volume":"48","author":"Gladding","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"267120","DOI":"10.1100\/2012\/267120","article-title":"Distribution of extrasynaptic NMDA receptors on neurons","volume":"2012","author":"Petralia","year":"2012","journal-title":"Sci. World J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","article-title":"Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine","volume":"81","author":"Lener","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.biopsych.2016.02.009","article-title":"Bidirectional homeostatic regulation of a depression-related brain state by gamma-aminobutyric acidergic deficits and ketamine treatment","volume":"80","author":"Ren","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.biopsych.2016.02.031","article-title":"Gamma-Aminobutyric Acidergic Projections From the Dorsal Raphe to the Nucleus Accumbens Are Regulated by Neuromedin U","volume":"80","author":"Kasper","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Adeel, M., Chen, C.-C., Lin, B.-S., Chen, H.-C., Liou, J.-C., Li, Y.-T., and Peng, C.-W. (2022). Safety of Special Waveform of Transcranial Electrical Stimulation (TES): In Vivo Assessment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126850"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"717157","DOI":"10.3389\/fimmu.2021.717157","article-title":"Kynurenic Acid and Its Synthetic Derivatives Protect against Sepsis-Associated Neutrophil Activation and Brain Mitochondrial Dysfunction in Rats","volume":"12","author":"Poles","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Szabo, M., Lajk\u00f3, N., Dulka, K., Szatm\u00e1ri, I., F\u00fcl\u00f6p, F., Mih\u00e1ly, A., V\u00e9csei, L., and Gulya, K. (2022). Kynurenic Acid and Its Analog SZR104 Exhibit Strong Antiinflammatory Effects and Alter the Intracellular Distribution and Methylation Patterns of H3 Histones in Immunochallenged Microglia-Enriched Cultures of Newborn Rat Brains. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031079"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"607","DOI":"10.17219\/acem\/166476","article-title":"Advances in EEG-based functional connectivity approaches to the study of the central nervous system in health and disease","volume":"32","author":"Gregorio","year":"2023","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1038\/s41380-020-00951-9","article-title":"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: A meta-analysis of 101 studies","volume":"26","author":"Marx","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","article-title":"The kynurenine pathway in schizophrenia and bipolar disorder","volume":"112","author":"Erhardt","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Battaglia, S., Nazzi, C., and Thayer, J.F. (2023). Fear-induced bradycardia in mental disorders: Foundations, current advances, future perspectives. Neurosci. Biobehav. Rev., 149.","DOI":"10.1016\/j.neubiorev.2023.105163"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.tins.2022.04.003","article-title":"Functional interplay between central and autonomic nervous systems in human fear conditioning","volume":"45","author":"Battaglia","year":"2022","journal-title":"Trends Neurosci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"103963","DOI":"10.1016\/j.brat.2021.103963","article-title":"Frozen in (e) motion: How reactive motor inhibition is influenced by the emotional content of stimuli in healthy and psychiatric populations","volume":"146","author":"Battaglia","year":"2021","journal-title":"Behav. Res. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neubiorev.2021.04.036","article-title":"Memories are not written in stone: Re-writing fear memories by means of non-invasive brain stimulation and optogenetic manipulations","volume":"127","author":"Borgomaneri","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jad.2021.02.076","article-title":"Don\u2019t hurt me no more: State-dependent transcranial magnetic stimulation for the treatment of specific phobia","volume":"286","author":"Borgomaneri","year":"2021","journal-title":"J. Affect. Disord."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"100034","DOI":"10.1016\/j.bbih.2019.100034","article-title":"Neuroinflammation and glial cell activation in mental disorders","volume":"2","author":"Almeida","year":"2020","journal-title":"Brain Behav. Immun.-Health"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"998714","DOI":"10.3389\/fnbeh.2022.998714","article-title":"Stopping in (e)motion: Reactive action inhibition when facing valence-independent emotional stimuli","volume":"16","author":"Battaglia","year":"2022","journal-title":"Front. Behav. Neurosci."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Di Gregorio, F., La Porta, F., Petrone, V., Battaglia, S., Orlandi, S., Ippolito, G., Romei, V., Piperno, R., and Lullini, G. (2022). Accuracy of EEG biomarkers in the detection of clinical outcome in disorders of consciousness after severe acquired brain injury: Preliminary results of a pilot study using a machine learning approach. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081897"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"946263","DOI":"10.3389\/fnbeh.2022.946263","article-title":"The influence of vicarious fear-learning in \u201cinfecting\u201d reactive action inhibition","volume":"16","author":"Battaglia","year":"2022","journal-title":"Front. Behav. Neurosci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: When physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00702-016-1615-5","article-title":"A comparative assessment of two kynurenic acid analogs in the formalin model of trigeminal activation: A behavioral, immunohistochemical and pharmacokinetic study","volume":"124","author":"Veres","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1268156","DOI":"10.3389\/fnbeh.2023.1268156","article-title":"Towards a mechanistic understanding of depression, anxiety, and their comorbidity: Perspectives from cognitive neuroscience","volume":"17","author":"Tanaka","year":"2023","journal-title":"Front. Behav. Neurosci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"102948","DOI":"10.1016\/j.autneu.2022.102948","article-title":"Cognition, emotion, and the central autonomic network","volume":"238","author":"Quadt","year":"2022","journal-title":"Auton. Neurosci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cogdev.2007.08.004","article-title":"The self-regulating brain: Cortical-subcortical feedback and the development of intelligent action","volume":"22","author":"Lewis","year":"2007","journal-title":"Cogn. Dev."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Maiese, M. (2010). Embodiment, Emotion, and Cognition, Springer.","DOI":"10.1057\/9780230297715"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/jpet.116.237503","article-title":"Oxidative Stress and the Central Nervous System","volume":"360","author":"Salim","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1038\/sj.bjp.0706400","article-title":"The role of inflammation in CNS injury and disease","volume":"147","author":"Lucas","year":"2006","journal-title":"Br. J. Pharm."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/B978-0-444-53491-0.00006-7","article-title":"Interaction between cognition, emotion, and the autonomic nervous system","volume":"Volume 117","author":"Critchley","year":"2013","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00702-016-1652-0","article-title":"Motion and emotion: Anxiety\u2013axial connections in Parkinson\u2019s disease","volume":"124","author":"Jech","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_131","unstructured":"Jawer, M.A. (2020). Sensitive Soul: The Unseen Role of Emotion in Extraordinary States, Simon and Schuster."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13052-018-0563-0","article-title":"Possible strategies to cross the blood-brain barrier","volume":"44","author":"Bellettato","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Upadhyay, R.K. (2014). Drug delivery systems, CNS protection, and the blood brain barrier. BioMed Res. Int., 2014.","DOI":"10.1155\/2014\/869269"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood\u2013brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_135","unstructured":"Gawdi, R., Shumway, K.R., and Emmady, P.D. (2023). StatPearls, StatPearls Publishing LLC."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/157015908785777210","article-title":"Brain endothelial cell-cell junctions: How to \u201copen\u201d the blood brain barrier","volume":"6","author":"Stamatovic","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2174\/13816128113199990463","article-title":"Transporters at CNS barrier sites: Obstacles or opportunities for drug delivery?","volume":"20","author":"Slosky","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.43.100901.140204","article-title":"The role of drug transporters at the blood-brain barrier","volume":"43","author":"Gaillard","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1504\/IJCBDD.2013.052195","article-title":"Analysing molecular polar surface descriptors to predict blood-brain barrier permeation","volume":"6","author":"Shityakov","year":"2013","journal-title":"Int. J. Comput. Biol. Drug Des."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-8993(80)91004-5","article-title":"Polarity of the blood-brain barrier: Distribution of enzymes between the luminal and antiluminal membranes of brain capillary endothelial cells","volume":"192","author":"Betz","year":"1980","journal-title":"Brain Res."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Janicka, M., Sztanke, M., and Sztanke, K. (2020). Predicting the blood-brain barrier permeability of new drug-like compounds via HPLC with various stationary phases. Molecules, 25.","DOI":"10.3390\/molecules25030487"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"122759","DOI":"10.1016\/j.ijpharm.2023.122759","article-title":"Access to the CNS: Strategies to overcome the BBB","volume":"636","author":"Bermejo","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.106.106484","article-title":"Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1","volume":"319","author":"Liu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_144","first-page":"749","article-title":"Systemic delivery to central nervous system by engineered PLGA nanoparticles","volume":"8","author":"Cai","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"985378","DOI":"10.3389\/fimmu.2022.985378","article-title":"Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","article-title":"Kynurenines: From the perspective of major psychiatric disorders","volume":"279","author":"Myint","year":"2012","journal-title":"FEBS J."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"319","DOI":"10.31887\/DCNS.2009.11.3\/nmueller","article-title":"The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders-relation to drug treatment","volume":"11","author":"Myint","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Mithaiwala, M.N., Santana-Coelho, D., Porter, G.A., and O\u2019Connor, J.C. (2021). Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications. Cells, 10.","DOI":"10.3390\/cells10061548"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00109-013-1046-9","article-title":"The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease","volume":"91","author":"Amaral","year":"2013","journal-title":"J. Mol. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3389\/fimmu.2017.01957","article-title":"Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions","volume":"8","author":"Wirthgen","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s11064-022-03546-8","article-title":"Kynurenine Metabolism and Alzheimer\u2019s Disease: The Potential Targets and Approaches","volume":"47","author":"Sharma","year":"2022","journal-title":"Neurochem. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"C818","DOI":"10.1152\/ajpcell.00580.2019","article-title":"The kynurenine connection: How exercise shifts muscle tryptophan metabolism and affects energy homeostasis, the immune system, and the brain","volume":"318","author":"Martin","year":"2020","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuropharm.2016.03.013","article-title":"Kynurenine pathway metabolites and enzymes involved in redox reactions","volume":"112","author":"Pineda","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/02648725.2021.1989847","article-title":"Gut-microbiota derived bioactive metabolites and their functions in host physiology","volume":"37","author":"Debnath","year":"2021","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.molmed.2021.07.006","article-title":"The kynurenine pathway in chronic diseases: A compensatory mechanism or a driving force?","volume":"27","author":"Joisten","year":"2021","journal-title":"Trends Mol. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"IJTR.S2097","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: Disease and healthy states","volume":"2","author":"Chen","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1178646919852996","DOI":"10.1177\/1178646919852996","article-title":"Microorganisms, tryptophan metabolism, and kynurenine pathway: A complex interconnected loop influencing human health status","volume":"12","author":"Dehhaghi","year":"2019","journal-title":"Int. J. Tryptophan Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"8793","DOI":"10.1080\/10408398.2021.1934813","article-title":"The therapeutic potential of diet on immune-related diseases: Based on the regulation on tryptophan metabolism","volume":"62","author":"Lin","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3389\/fimmu.2020.01497","article-title":"Immunomodulatory roles of tryptophan metabolites in inflammation and cancer","volume":"11","author":"Fallarino","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"IJTR.S12536","DOI":"10.4137\/IJTR.S12536","article-title":"Kynurenic acid in the digestive system\u2014New facts, new challenges","volume":"6","author":"Turski","year":"2013","journal-title":"Int. J. Tryptophan Res."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"T\u00f6r\u00f6k, N., Tanaka, M., and V\u00e9csei, L. (2020). Searching for peripheral biomarkers in neurodegenerative diseases: The tryptophan-kynurenine metabolic pathway. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints202011.0396.v1"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Balogh, L., Tanaka, M., T\u00f6r\u00f6k, N., V\u00e9csei, L., and Taguchi, S. (2021). Crosstalk between existential phenomenological psychotherapy and neurological sciences in mood and anxiety disorders. Biomedicines, 9.","DOI":"10.20944\/preprints202012.0625.v3"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s43440-020-00067-5","article-title":"Antidepressant-like effects of kynurenic acid in a modified forced swim test","volume":"72","author":"Tanaka","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coph.2003.10.006","article-title":"The kynurenine pathway of tryptophan degradation as a drug target","volume":"4","author":"Schwarcz","year":"2004","journal-title":"Curr. Opin. Pharm."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"702764","DOI":"10.3389\/fimmu.2021.702764","article-title":"Kynurenic Acid and Its Analogue SZR-72 Ameliorate the Severity of Experimental Acute Necrotizing Pancreatitis","volume":"12","author":"Balla","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00702-011-0692-8","article-title":"Behavioural studies with a newly developed neuroprotective KYNA-amide","volume":"119","author":"Varga","year":"2012","journal-title":"J. Neural Transm."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.neuropharm.2009.06.033","article-title":"l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus","volume":"57","author":"Varga","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3389\/fimmu.2019.01406","article-title":"The Opposite Effects of Kynurenic Acid and Different Kynurenic Acid Analogs on Tumor Necrosis Factor-\u03b1 (TNF-\u03b1) Production and Tumor Necrosis Factor-Stimulated Gene-6 (TSG-6) Expression","volume":"10","author":"Lantos","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00702-011-0755-x","article-title":"A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study: Special issue related to kynurenine","volume":"119","author":"Demeter","year":"2012","journal-title":"J. Neural Transm."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Martos, D., Tuka, B., Tanaka, M., V\u00e9csei, L., and Telegdy, G. (2022). Memory enhancement with kynurenic acid and its mechanisms in neurotransmission. Biomedicines, 10.","DOI":"10.20944\/preprints202203.0327.v1"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Benson, H.A., and Roberts, M.S. (2021). Fundamentals of Drug Delivery, Wiley.","DOI":"10.1002\/9781119769644"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"McCarson, K.E. (2020). Transgenic Mouse: Methods and Protocols, Humana.","DOI":"10.1007\/978-1-4939-9837-1"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-animal-022516-022754","article-title":"Behavioral phenotyping assays for genetic mouse models of neurodevelopmental, neurodegenerative, and psychiatric disorders","volume":"5","author":"Crawley","year":"2017","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Tanaka, M., T\u00f6r\u00f6k, N., T\u00f3th, F., Szab\u00f3, \u00c1., and V\u00e9csei, L. (2021). Co-players in chronic pain: Neuroinflammation and the tryptophan-kynurenine metabolic pathway. Biomedicines, 9.","DOI":"10.20944\/preprints202106.0128.v1"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Moln\u00e1r, K., L\u0151rinczi, B., Fazakas, C., Szatm\u00e1ri, I., F\u00fcl\u00f6p, F., Kmetyk\u00f3, N., Berkecz, R., Ilisz, I., Krizbai, I.A., and Wilhelm, I. (2021). Szr-104, a novel kynurenic acid analogue with high permeability through the blood\u2013brain barrier. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13010061"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Castillo-Mariqueo, L., and Gim\u00e9nez-Llort, L. (2022). Impact of Behavioral Assessment and Re-Test as Functional Trainings That Modify Survival, Anxiety and Functional Profile (Physical Endurance and Motor Learning) of Old Male and Female 3xTg-AD Mice and NTg Mice with Normal Aging. Biomedicines, 10.","DOI":"10.3390\/biomedicines10050973"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Lee, E.C., Hong, D.-Y., Lee, D.-H., Park, S.-W., Lee, J.Y., Jeong, J.H., Kim, E.-Y., Chung, H.-M., Hong, K.-S., and Park, S.-P. (2022). Inflammation and rho-associated protein kinase-induced brain changes in vascular dementia. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020446"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Smagin, D.A., Kovalenko, I.L., Galyamina, A.G., Belozertseva, I.V., Tamkovich, N.V., Baranov, K.O., and Kudryavtseva, N.N. (2021). Chronic Lithium Treatment affects anxious behaviors and theExpression of serotonergic genes in Midbrain Raphe nuclei of defeated male mice. Biomedicines, 9.","DOI":"10.1101\/2021.01.04.425168"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Vila-Merkle, H., Gonz\u00e1lez-Mart\u00ednez, A., Campos-Jim\u00e9nez, R., Mart\u00ednez-Ric\u00f3s, J., Teruel-Mart\u00ed, V., Blasco-Serra, A., Lloret, A., Celada, P., and Cervera-Ferri, A. (2021). The Oscillatory Profile Induced by the Anxiogenic Drug FG-7142 in the Amygdala\u2013Hippocampal Network Is Reversed by Infralimbic Deep Brain Stimulation: Relevance for Mood Disorders. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070783"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Santana-Santana, M., Bayascas, J.-R., and Gim\u00e9nez-Llort, L. (2021). Fine-Tuning the PI3K\/Akt Signaling Pathway Intensity by Sex and Genotype-Load: Sex-Dependent Homozygotic Threshold for Somatic Growth but Feminization of Anxious Phenotype in Middle-Aged PDK1 K465E Knock-In and Heterozygous Mice. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070747"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Muntsant, A., and Gim\u00e9nez-Llort, L. (2021). Genotype Load Modulates Amyloid Burden and Anxiety-Like Patterns in Male 3xTg-AD Survivors despite Similar Neuro-Immunoendocrine, Synaptic and Cognitive Impairments. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070715"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Gim\u00e9nez-Llort, L., Marin-Pardo, D., Marazuela, P., and Hern\u00e1ndez-Guillam\u00f3n, M. (2021). Survival Bias and Crosstalk between Chronological and Behavioral Age: Age-and Genotype-Sensitivity Tests Define Behavioral Signatures in Middle-Aged, Old, and Long-Lived Mice with Normal and AD-Associated Aging. Biomedicines, 9.","DOI":"10.3390\/biomedicines9060636"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Samra, A.I., Kamel, A.S., Abdallah, D.M., El Fattah, M.A.A., Ahmed, K.A., and El-Abhar, H.S. (2023). Preclinical Evidence for the Role of the Yin\/Yang Angiotensin System Components in Autism Spectrum Disorder: A Therapeutic Target of Astaxanthin. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123156"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Canfora, F., Ottaviani, G., Calabria, E., Pecoraro, G., Leuci, S., Coppola, N., Sansone, M., Rupel, K., Biasotto, M., and Di Lenarda, R. (2023). Advancements in Understanding and Classifying Chronic Orofacial Pain: Key Insights from Biopsychosocial Models and International Classifications (ICHD-3, ICD-11, ICOP). Biomedicines, 11.","DOI":"10.3390\/biomedicines11123266"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Cruz-Mart\u00ednez, Y., Aguilar-Ponce, L., Romo-Araiza, A., Ch\u00e1vez-Guerra, A., Marti\u00f1\u00f3n, S., Ibarra-Garc\u00eda, A.P., Arias-Santiago, S., G\u00e1lvez-Susano, V., and Ibarra, A. (2024). Supplementation with a Symbiotic Induced Neuroprotection and Improved Memory in Rats with Ischemic Stroke. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010209"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Baliellas, D.E., Barros, M.P., Vardaris, C.V., Guariroba, M., Poppe, S.C., Martins, M.F., Pereira, \u00c1.A., and Bondan, E.F. (2023). Propentofylline Improves Thiol-Based Antioxidant Defenses and Limits Lipid Peroxidation following Gliotoxic Injury in the Rat Brainstem. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061652"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Olasehinde, T.A., and Olaokun, O.O. (2024). The Beneficial Role of Apigenin against Cognitive and Neurobehavioural Dysfunction: A Systematic Review of Preclinical Investigations. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010178"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Li, T., Xu, G., Yi, J., and Huang, Y. (2022). Intraoperative Hypothermia Induces Vascular Dysfunction in the CA1 Region of Rat Hippocampus. Brain Sci., 12.","DOI":"10.3390\/brainsci12060692"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Chen, B., Wei, S., Low, S.W., Poore, C.P., Lee, A.T., Nilius, B., and Liao, P. (2023). TRPM4 Blocking Antibody Protects Cerebral Vasculature in Delayed Stroke Reperfusion. Biomedicines, 11.","DOI":"10.3390\/biomedicines11051480"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Salafutdinov, I.I., Gatina, D.Z., Markelova, M.I., Garanina, E.E., Malanin, S.Y., Gazizov, I.M., Izmailov, A.A., Rizvanov, A.A., Islamov, R.R., and Palot\u00e1s, A. (2023). A Biosafety Study of Human Umbilical Cord Blood Mononuclear Cells Transduced with Adenoviral Vector Carrying Human Vascular Endothelial Growth Factor cDNA In Vitro. Biomedicines, 11.","DOI":"10.3390\/biomedicines11072020"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Gaebler, A.J., Finner-Pr\u00e9vel, M., Sudar, F.P., Langer, F.H., Keskin, F., Gebel, A., Zweerings, J., and Mathiak, K. (2022). The interplay between vitamin D, exposure of anticholinergic antipsychotics and cognition in schizophrenia. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051096"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Simonato, M., Dall\u2019Acqua, S., Zilli, C., Sut, S., Tenconi, R., Gallo, N., Sfriso, P., Sartori, L., Cavallin, F., and Fiocco, U. (2021). Tryptophan metabolites, cytokines, and fatty acid binding protein 2 in myalgic encephalomyelitis\/chronic fatigue syndrome. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111724"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Panov, G., Dyulgerova, S., and Panova, P. (2023). Cognition in Patients with Schizophrenia: Interplay between Working Memory, Disorganized Symptoms, Dissociation, and the Onset and Duration of Psychosis, as Well as Resistance to Treatment. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123114"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"de Oliveira, M., Santinelli, F.B., Lisboa-Filho, P.N., and Barbieri, F.A. (2023). The blood concentration of metallic nanoparticles is related to cognitive performance in people with multiple sclerosis: An exploratory analysis. Biomedicines, 11.","DOI":"10.3390\/biomedicines11071819"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Rajkumar, R.P. (2023). Biomarkers of Neurodegeneration in Post-Traumatic Stress Disorder: An Integrative Review. Biomedicines, 11.","DOI":"10.20944\/preprints202303.0533.v1"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Stojsavljevi\u0107, A., Laki\u0107evi\u0107, N., and Pavlovi\u0107, S. (2023). Mercury and Autism Spectrum Disorder: Exploring the Link through Comprehensive Review and Meta-Analysis. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123344"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Papageorgiou, G., Kasselimis, D., Laskaris, N., and Potagas, C. (2023). Unraveling the Thread of Aphasia Rehabilitation: A Translational Cognitive Perspective. Biomedicines, 11.","DOI":"10.3390\/biomedicines11102856"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"932635","DOI":"10.3389\/fpsyt.2022.932635","article-title":"Case report: Depressive disorder with peripartum onset camouflages suspected intracranial tuberculoma","volume":"13","author":"Zakia","year":"2022","journal-title":"Front. Psychiatry"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1192562","DOI":"10.3389\/fpsyt.2023.1192562","article-title":"Early-onset Alzheimer\u2019s disease with depression as the first symptom: A case report with literature review","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Psychiatry"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Komatsu, H., Watanabe, E., and Fukuchi, M. (2021). Psychiatric neural networks and precision therapeutics by machine learning. Biomedicines, 9.","DOI":"10.3390\/biomedicines9040403"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Koul, A.M., Ahmad, F., Bhat, A., Aein, Q.-U., Ahmad, A., Reshi, A.A., and Kaul, R.-U.-R. (2023). Unraveling Down Syndrome: From Genetic Anomaly to Artificial Intelligence-Enhanced Diagnosis. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123284"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Ikonnikova, A., Anisimova, A., Galkin, S., Gunchenko, A., Abdukhalikova, Z., Filippova, M., Surzhikov, S., Selyaeva, L., Shershov, V., and Zasedatelev, A. (2022). Genetic Association Study and Machine Learning to Investigate Differences in Platelet Reactivity in Patients with Acute Ischemic Stroke Treated with Aspirin. Biomedicines, 10.","DOI":"10.3390\/biomedicines10102564"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Rassler, B., Blinowska, K., Kaminski, M., and Pfurtscheller, G. (2023). Analysis of Respiratory Sinus Arrhythmia and Directed Information Flow between Brain and Body Indicate Different Management Strategies of fMRI-Related Anxiety. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041028"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/jmf.2021.0084","article-title":"The role of resveratrol in mild cognitive impairment and Alzheimer\u2019s disease: A systematic review","volume":"25","author":"Buglio","year":"2022","journal-title":"J. Med. Food"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157340909788451892","article-title":"Computational models for central nervous system penetration","volume":"5","author":"Klon","year":"2009","journal-title":"Curr. Comput.-Aided Drug Des."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Barbalho, S.M., Direito, R., Laurindo, L.F., Marton, L.T., Guiguer, E.L., Goulart, R.d.A., Tofano, R.J., Carvalho, A.C., Flato, U.A.P., and Capelluppi Tofano, V.A. (2022). Ginkgo biloba in the aging process: A narrative review. Antioxidants, 11.","DOI":"10.3390\/antiox11030525"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Kosz\u0142a, O., St\u0119pnicki, P., Zi\u0119ba, A., Grudzi\u0144ska, A., Matosiuk, D., and Kaczor, A.A. (2021). Current Approaches and Tools Used in Drug Development against Parkinson\u2019s Disease. Biomolecules, 11.","DOI":"10.3390\/biom11060897"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0004867421998795","article-title":"A systematic review of the antidepressant effects of curcumin: Beyond monoamines theory","volume":"55","author":"Matias","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Tanaka, M., and V\u00e9csei, L. (2024). From Lab to Life: Exploring Cutting-Edge Models for Neurological and Psychiatric Disorders. Biomedicines, 12.","DOI":"10.20944\/preprints202403.0259.v1"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"de Albuquerque, L.L., Pantovic, M., Clingo, M., Fischer, K., Jalene, S., Landers, M., Mari, Z., and Poston, B. (2023). A Single Application of Cerebellar Transcranial Direct Current Stimulation Fails to Enhance Motor Skill Acquisition in Parkinson\u2019s Disease: A Pilot Study. Biomedicines, 11.","DOI":"10.3390\/biomedicines11082219"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Senevirathne, D.K.L., Mahboob, A., Zhai, K., Paul, P., Kammen, A., Lee, D.J., Yousef, M.S., and Chaari, A. (2023). Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson\u2019s and Alzheimer\u2019s Disease Therapy. Cells, 12.","DOI":"10.3390\/cells12111478"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"847618","DOI":"10.3389\/fpsyt.2022.847618","article-title":"Case Report: Low-Frequency Repetitive Transcranial Magnetic Stimulation to Dorsolateral Prefrontal Cortex and Auditory Cortex in a Patient with Tinnitus and Depression","volume":"13","author":"Chang","year":"2022","journal-title":"Front. Psychiatry"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.3389\/fpsyt.2022.1068054","article-title":"Various neuromodulation methods including Deep Brain Stimulation of the medial forebrain bundle combined with psychopharmacotherapy of treatment-resistant depression\u2014Case report","volume":"13","author":"Rymaszewska","year":"2023","journal-title":"Front. Psychiatry"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/7854_2022_365","article-title":"Psychedelics in the Treatment of Headache and Chronic Pain Disorders","volume":"56","author":"Schindler","year":"2022","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"927075","DOI":"10.3389\/fpsyt.2022.927075","article-title":"Meta-analysis of structural and functional brain abnormalities in cocaine addiction","volume":"13","author":"Dang","year":"2022","journal-title":"Front. Psychiatry"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Borb\u00e9ly, K., Emri, M., Kenessey, I., T\u00f3th, M., Singer, J., Barsi, P., Vajda, Z., P\u00e1l, E., T\u00f3th, Z., and Beyer, T. (2022). Pet\/Mri in the presurgical evaluation of patients with epilepsy: A concordance analysis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10050949"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1054380","DOI":"10.3389\/fpsyt.2022.1054380","article-title":"Altered striatal functional connectivity and structural dysconnectivity in individuals with bipolar disorder: A resting state magnetic resonance imaging study","volume":"13","author":"Qiang","year":"2022","journal-title":"Front. Psychiatry"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1098573","DOI":"10.3389\/fnins.2023.1098573","article-title":"Altered brain activities in mesocorticolimbic pathway in primary dysmenorrhea patients of long-term menstrual pain","volume":"17","author":"Liu","year":"2023","journal-title":"Front. Neurosci."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1149663","DOI":"10.3389\/fpsyt.2023.1149663","article-title":"The non-linear correlation between the volume of cerebral white matter lesions and incidence of bipolar disorder: A secondary analysis of data from a cross-sectional study","volume":"14","author":"Du","year":"2023","journal-title":"Front. Psychiatry"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1188603","DOI":"10.3389\/fpsyt.2023.1188603","article-title":"Unraveling the pathophysiology of schizophrenia: Insights from structural magnetic resonance imaging studies","volume":"14","author":"Adamu","year":"2023","journal-title":"Front. Psychiatry"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1027907","DOI":"10.3389\/fpsyt.2022.1027907","article-title":"Gray matter, white matter and cerebrospinal fluid abnormalities in Parkinson\u2019s disease: A voxel-based morphometry study","volume":"13","author":"Nyatega","year":"2022","journal-title":"Front. Psychiatry"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1205126","DOI":"10.3389\/fpsyt.2023.1205126","article-title":"Antidepressant-induced mania in panic disorder: A single-case study of clinical and functional connectivity characteristics","volume":"14","author":"Kim","year":"2023","journal-title":"Front. Psychiatry"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1184797","DOI":"10.3389\/fpsyt.2023.1184797","article-title":"Differential responses from the left postcentral gyrus, right middle frontal gyrus, and precuneus to meal ingestion in patients with functional dyspepsia","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Psychiatry"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1219592","DOI":"10.3389\/fpsyt.2023.1219592","article-title":"Transient splenial lesion syndrome in bipolar-II disorder: A case report highlighting reversible brain changes during hypomanic episodes","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Psychiatry"},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Manuello, J., Costa, T., Cauda, F., and Liloia, D. (2022). Six actions to improve detection of critical features for neuroimaging coordinate-based meta-analysis preparation. Neurosci. Biobehav. Rev., 137.","DOI":"10.1016\/j.neubiorev.2022.104659"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ejoc.201501400","article-title":"The synthesis of quinolone natural products from Pseudonocardia sp.","volume":"2016","author":"Salvaggio","year":"2015","journal-title":"Eur. J. Org. Chem."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1021\/acs.jnatprod.0c00171","article-title":"Synthesis and antimicrobial activity of Burkholderia-related 4-hydroxy-3-methyl-2-alkenylquinolines (HMAQs) and their N-oxide counterparts","volume":"83","author":"Piochon","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bmcl.2007.10.097","article-title":"Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors","volume":"18","author":"Nam","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejmech.2014.05.064","article-title":"Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents","volume":"82","author":"Vyas","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pnpbp.2008.10.008","article-title":"Central or peripheral norepinephrine depletion enhances MK-801-induced plasma corticosterone level in mice","volume":"33","author":"Kim","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Szab\u00f3, \u00c1., V\u00e9csei, L., and Gim\u00e9nez-Llort, L. (2023). Emerging translational research in neurological and psychiatric diseases: From in vitro to in vivo models. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202310.0800.v1"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"505","DOI":"10.17219\/acem\/165944","article-title":"Preclinical modeling in depression and anxiety: Current challenges and future research directions","volume":"32","author":"Tanaka","year":"2023","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(79)90279-6","article-title":"Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats","volume":"59","author":"Sturgeon","year":"1979","journal-title":"Eur. J. Pharm."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0028-3908(90)90015-J","article-title":"D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia","volume":"29","author":"Contreras","year":"1990","journal-title":"Neuropharmacology"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"109940","DOI":"10.1016\/j.jneumeth.2023.109940","article-title":"Comparison of automated video tracking systems in the open field test: ANY-Maze versus EthoVision XT","volume":"397","author":"Lim","year":"2023","journal-title":"J. Neurosci. Methods"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/0269881107073199","article-title":"The Open Field Test: Reinventing the wheel","volume":"21","author":"Stanford","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The Open-Field Test: A critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"key":"ref_238","first-page":"49","article-title":"The rotarod","volume":"42","author":"Pritchett","year":"2003","journal-title":"Contemp. Top. Lab. Anim. Sci."},{"key":"ref_239","first-page":"e55491","article-title":"Battery of Behavioral Tests Assessing General Locomotion, Muscular Strength, and Coordination in Mice","volume":"131","author":"Osmon","year":"2018","journal-title":"J. Vis. Exp."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/6\/3394\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:14:52Z","timestamp":1760105692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/6\/3394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,16]]},"references-count":239,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["ijms25063394"],"URL":"https:\/\/doi.org\/10.3390\/ijms25063394","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,16]]}}}